Wyeth Prevnar Letter
This article was originally published in The Pink Sheet Daily
Executive Summary
Wyeth is alerting providers to a 25% cut in monthly allocations of the pneumococcal conjugate vaccine Prevnar via a Feb. 12 1"Dear Customer" letter
You may also be interested in...
Wyeth Prevnar Manufacturing Delays Extend Allocation Plan To July; Four-Dose Schedule Suspended
Providers will receive 80% of their average order until at least mid-year. CDC estimates the temporary change to the three-dose schedule will conserve over 1 mil. doses of the vaccine.
Merck Tax Settlement Could Be Smaller Than GSK’s $3.4 Bil. IRS Deal
A possible settlement between Merck and tax authorities could be significantly smaller than GlaxoSmithKline's recent settlement with the IRS based on the companies' projected liability
McKindler? New Pfizer CEO Echoes McKinnell’s Views On Payers, Scale
Pfizer's success will depend on its ability to negotiate the paradox of increasing demand for pharmaceuticals coupled with growing attempts to restrain costs, CEO Jeffrey Kindler said